Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

China Jo-Jo Drugstores Announces Second Quarter Fiscal 2014 Conference Call



 China Jo-Jo Drugstores Announces Second Quarter Fiscal 2014 Conference Call

PR Newswire

HANGZHOU, China, Nov. 13, 2013

HANGZHOU, China, Nov. 13, 2013 /PRNewswire/ -- China Jo-Jo Drugstores, Inc.
(NASDAQ:CJJD) (the "Company"), a retail and wholesale distributor of
pharmaceutical and other healthcare products in China, today announced that
the Company will hold its second quarter fiscal 2014 earnings call on Friday
November 15, 2013 at 8:00 a.m. Eastern Time. The Company plans to issue its
earnings press release on Thursday, November 14, 2013, after market closes.

To participate in the conference call (identification number 4651164), please
dial 1-888-846-5003 from North America. International participants can access
the call by dialing 1-480-629-9586. A live audio webcast of this conference
call will be available under the Investor Relations section of the Company's
website at http://www.chinajojodrugstores.com. A replay of the call will be
available beginning the same day at approximately 11 a.m. Eastern Time by
dialing 1-877-870-5176 or -1-858-384-5517 with pin # 4651164. The replay will
also be available on the company website.

About China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc., through its subsidiaries and contractually
controlled affiliates, is a retailer and wholesale distributor of
pharmaceutical and other healthcare products in the People's Republic of
China.  As of September 30, 2013, the Company had 51 retail pharmacies
throughout Zhejiang Province and Shanghai.

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: Certain of the statements made in the press release constitute
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements can be identified by the use
of forward-looking terminology such as "believe," "expect," "may," "will,"
"should," "project," "plan," "seek," "intend," or "anticipate" or the negative
thereof or comparable terminology. Such statements typically involve risks and
uncertainties and may include financial projections or information regarding
the progress of new product development. Actual results could differ
materially from the expectations reflected in such forward-looking statements
as a result of a variety of factors, including the risks associated with the
effect of changing economic conditions in The People's Republic of China,
variations in cash flow, reliance on collaborative retail partners and on new
product development, variations in new product development, risks associated
with rapid technological change, and the potential of introduced or undetected
flaws and defects in products, and other risk factors detailed in reports
filed with the Securities and Exchange Commission from time to time.

Contacts

China Jo-Jo Drugstores, Inc.
Ming Zhao
Chief Financial Officer
Tel: (561) 372-5555
Email: frank.zhao@jojodrugstores.com 

SOURCE China Jo-Jo Drugstores, Inc.

Website: http://www.chinajojodrugstores.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement